In patients with lupus, those taking prednisone or demonstrating active disease and a more recent initial episode are more likely to have pericarditis recurrence. Overall recurrence was lower than ...

Approximately 15% to 30% of patients have lupus nephritis at the time of SLE diagnosis, with more patients at risk of developing lupus nephritis over the course of their disease. An estimated 30% to ...

The data, which so far have been presented only in abstract form, suggest that budesonide is efficient in inducing stable remission, is superior compared with a standard prednisone-tapering ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis. Pericarditis is the most common cardiac ...

Factors associated with pericarditis recurrence include younger age, prednisone treatment, active systemic lupus erythematosus, and time since initial episode. HealthDay News — For patients with ...

A prednisone taper gradually reduces your corticosteroid dose over days, weeks, or months to prevent prednisone withdrawal. Stopping prednisone abruptly can lead to adrenal insufficiency, which causes ...

Conclusions: Achieving rapid remission after LLDAS attainment remains challenging for most SLE patients, mainly due to difficulties in reducing prednisone dosage to ≤5 mg/day. Systemic lupus ...

In this recording from our virtual webinar on the American College of Rheumatology’s new Lupus Nephritis Treatment Guidelines, learn more about evidence-based, expert recommendations for adults and ...

Lupus is an autoimmune condition that can cause pain, problems in multiple organs and systems of the body, inflammation, and complications that range from minor to life threatening. The body’s ...